Muco-penetrating approaches that have made it to the clinic include PEGylated adrenomedullin (NCT04417036, phase II of BAY1097761 for acute respiratory distress syndrome), amikacin liposomes (FDA-approved for mycobacterium infections therapy) and ciprofloxacin liposomes (NCT02104245, phase III of ciprofloxacin liposomes for non-cystic fibrosis bronchiectasis), all showing better penetration and retention in the airways during delivery (Table 3)
Conjugate compounds are exported from the cell by GSH transporters, which requires ATP for active pumping [17]
According to our results, groups treated with chrysin and cisplatin show ROS at high levels
At the current time, the bioavailability of glutathione is thought to be extremely poor due to the hydrolytic enzymes that break down the glutathione upon ingestion
It prevents bacterial contamination, stabilises peptides, and extends the life of your research materials